Preventing Myocardial Infarction in Patients With Atrial Fibrillation: Another Piece of the Puzzle.

@article{Halperin2017PreventingMI,
  title={Preventing Myocardial Infarction in Patients With Atrial Fibrillation: Another Piece of the Puzzle.},
  author={Jonathan L. Halperin},
  journal={Journal of the American College of Cardiology},
  year={2017},
  volume={69 24},
  pages={
          2910-2912
        }
}
A conventional tenet of antithrombotic therapy for cardiovascular disease is the use of anticoagulant drugs to prevent formation of fibrin due to activation of the coagulation system in states of hemodynamic stasis, such as occurs in patients with atrial fibrillation (AF). Another is to use antiplatelet drugs to prevent atherothrombotic events, such as myocardial infarction (MI) due to plaque rupture in patients with coronary artery disease. In each situation, the intensity of therapy should be… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 17 REFERENCES

The aspirin controversy in primary prevention.

VIEW 1 EXCERPT